Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 401 | Bone Marrow Family | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
| 402 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 403 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 404 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 405 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 76 |
| 406 | Bone Marrow Family | Allogeneic | Langerhans Cell Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 407 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 408 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 409 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 410 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 411 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 412 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Germany | 70 |
| 413 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 414 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 415 | Bone Marrow Family | Allogeneic | Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 416 | Bone Marrow Family | Allogeneic | Secondary Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 417 | Bone Marrow Family | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 418 | Bone Marrow Family | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 419 | Bone Marrow | Allogeneic | Acute Leukemia Of Ambiguous Lineage | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 420 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 421 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 422 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 423 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 424 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 425 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 426 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 25 |
| 427 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 428 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 429 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 months |
| 430 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 431 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 432 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 433 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 434 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 435 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 436 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 437 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 438 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 439 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
| 440 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 441 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
| 442 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 443 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 444 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 445 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 446 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 447 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 448 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 75 |
| 449 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 450 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
| 451 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 452 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 453 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 34 |
| 454 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 455 | Bone Marrow | Allogeneic | Adrenoleukodystrophy (Ald) – Siemerling-Creutzfeldt Disease | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 456 | Bone Marrow | Allogeneic | Amegakaryocytic Thrombocytopenia | Hematology | 2023 | Standard Therapy | Poland | 6 months |
| 457 | Bone Marrow | Allogeneic | Anemia Fanconi | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 458 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 18 |
| 459 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 460 | Bone Marrow | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 461 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 462 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 463 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 464 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 465 | Bone Marrow | Allogeneic | Chronic Myeloid Leukemia Blast Crisis | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 466 | Bone Marrow | Allogeneic | Clippers Syndrome | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 467 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2023 | Standard Therapy | Poland | 6 months |
| 468 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 469 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 470 | Bone Marrow | Allogeneic | Hodgkin’s Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 23 |
| 471 | Bone Marrow | Allogeneic | Immunodeficiency – Xlp1 | Hematology | 2023 | Standard Therapy | Poland | 10 |
| 472 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 473 | Bone Marrow | Allogeneic | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 474 | Bone Marrow | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 22 |
| 475 | Bone Marrow | Allogeneic | Mitochondrial Neurogastrointestinal Encephalopathy | Hematology | 2023 | Standard Therapy | Poland | 33 |
| 476 | Bone Marrow | Allogeneic | Mixed Lineage Acute Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 477 | Bone Marrow | Allogeneic | Monocytopenia And Mycobacterial Infection (Monomac) Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 478 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 479 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Ih (Hurler) | Hematology | 2023 | Standard Therapy | Poland | 8 months |
| 480 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Iv | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 481 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 482 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 483 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 484 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 485 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 486 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 19 |
| 487 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 488 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 489 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 490 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 491 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 492 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 months |
| 493 | Bone Marrow | Allogeneic | Primary Combined Severe Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 494 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 495 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 496 | Bone Marrow | Allogeneic | Prolymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 497 | Bone Marrow | Allogeneic | Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 498 | Bone Marrow | Allogeneic | Secondary Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 499 | Bone Marrow | Allogeneic | Secondary Myelofibrosis Post Polycythemia Vera | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 500 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 11 |